923282-48-8

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 1-ethyl-4-nitro-1H-pyrazole-5-carboxylate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
Methyl 1ethyl4nitro1Hpyrazole5carboxylate is utilized as a precursor in the production of pesticides and herbicides, highlighting its role in agriculture for controlling pests and unwanted plant growth.
Used in Organic Chemistry:
Methyl 1-ethyl-4-nitro-1H-pyrazole-5-carboxylate is employed as a building block in organic chemistry for the construction of various heterocyclic compounds, which are essential in the creation of complex organic molecules with diverse applications.

Upstream product

• 138786-86-4 methyl 4-nitro-1H-pyrazole-3-carboxylate 
• 75-03-6 ethyl iodide 
• 138786-86-4 4-nitro-2H-pyrazole-3-carboxylic acid methyl ester 

Downstream Products

• 1199215-97-8 2-ethyl-4-nitropyrazole-3-carbonyl chloride 

Relevant academic research and scientific papers

AROMATIC DERIVATIVES, PREPARATION METHODS, AND MEDICAL USES THEREOF

The present disclosure relates generally to aromatic derivatives that are inhibitors of FGFR4 and are useful in treating FGFR4-associated diseases or conditions. Compositions containing the compounds of the present disclosure are also provided.

HETEROCYCLIC COMPOUND

The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

Pyrazolo pyrimidines useful as aurora kinase inhibitors

The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R2, R4, X1A, X2A, X1B, X2B, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.